Some products, like the over-the-counter supplement St
Certain factors may increase the likelihood of experiencing bloating on GLP-1 therapy, including: Pre-existing gastrointestinal conditions such as irritable bowel syndrome (IBS), functional dyspepsia, or small intestinal bacterial overgrowth (SIBO) Rapid dose escalation without adequate titration periods Dietary factors , particularly high intake of fermentable carbohydrates (FODMAPs), fatty foods, or carbonated beverages Concurrent medications that affect gastrointestinal motility Patients should be aware that GLP-1 receptor agonists have been associated with more serious gastrointestinal adverse effects, including pancreatitis (inflammation of the pancreas) and gallbladder disease
This medically supervised weight management medication helps you achieve a steady, healthy weight while boosting your confidence and long-term wellness for a transformative journey like no other
Form : Supplied as 5mg lyophilized powder in a 3mL sterile vial
Promotes neuroplasticity, memory and cognitive function by activating the HGF/c-Met receptor
The discontinuation rates due to adverse events, which were comparable to placebo, suggest that the transition to oral orforglipron is generally well-tolerated by patients already acclimated to incretin therapy
